Synthesis and effects on cell viability of flavonols and 3-methyl ether derivatives on human leukemia cells.
暂无分享,去创建一个
[1] F. Estévez,et al. Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells , 2014, Molecular carcinogenesis.
[2] F. Greco,et al. Flavonoids as prospective compounds for anti-cancer therapy. , 2013, The international journal of biochemistry & cell biology.
[3] Michael Wiese,et al. Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2. , 2013, European journal of medicinal chemistry.
[4] M. F. Proença,et al. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin. , 2013, European journal of medicinal chemistry.
[5] L. Monasta,et al. TRAIL-based therapeutic approaches for the treatment of pediatric malignancies. , 2013, Current medicinal chemistry.
[6] L. Ouyang,et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis , 2012, Cell proliferation.
[7] S. Cutler,et al. Cell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signaling. , 2012, European journal of medicinal chemistry.
[8] Jae In Lee,et al. An Effective Synthesis of 3-Methoxyflavones via 1-(2-Hydroxyphenyl)-2-methoxy-3-phenyl-1,3-propanediones , 2012 .
[9] F. Estévez,et al. Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway. , 2011, Cancer letters.
[10] R. Seger,et al. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. , 2011, Biochimica et biophysica acta.
[11] J. Buolamwini,et al. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity. , 2010, Biochemical pharmacology.
[12] Gen Sheng Wu. TRAIL as a target in anti-cancer therapy. , 2009, Cancer letters.
[13] G. Salvesen,et al. Human Caspases: Activation, Specificity, and Regulation* , 2009, The Journal of Biological Chemistry.
[14] Junying Yuan,et al. Caspases in apoptosis and beyond , 2008, Oncogene.
[15] Min Chen,et al. Synthesis of a library of glycosylated flavonols , 2008, Tetrahedron Letters.
[16] T. Walle. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? , 2007, Seminars in cancer biology.
[17] F. Estévez,et al. Acetyl derivative of quercetin 3-methyl ether-induced cell death in human leukemia cells is amplified by the inhibition of ERK. , 2007, Carcinogenesis.
[18] Rony Seger,et al. The MEK/ERK cascade: from signaling specificity to diverse functions. , 2007, Biochimica et biophysica acta.
[19] Wei Chen,et al. Differential regulation and properties of MAPKs , 2007, Oncogene.
[20] L. Goya,et al. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). , 2006, The Journal of nutrition.
[21] F. Estévez,et al. Phenylbenzopyrones structure-activity studies identify betuletol derivatives as potential antitumoral agents. , 2006, European journal of pharmacology.
[22] Joong-Hoon Ahn,et al. Complete assignment of 1H and 13C NMR data of some flavonol derivatives , 2005, Magnetic resonance in chemistry : MRC.
[23] T. Ho,et al. Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. , 2005, Biochemical pharmacology.
[24] Ching-Shu Lai,et al. Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells. , 2005, European journal of pharmacology.
[25] S. Shankar,et al. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[26] J. Dickenson,et al. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death. , 2004, European journal of pharmacology.
[27] H. Huynh,et al. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. , 2003, Carcinogenesis.
[28] G. Shore,et al. Regulation of apoptosis by endoplasmic reticulum pathways , 2003, Oncogene.
[29] S. Shen,et al. Differential apoptosis‐inducing effect of quercetin and its glycosides in human promyeloleukemic HL‐60 cells by alternative activation of the caspase 3 cascade , 2003, Journal of cellular biochemistry.
[30] Young-ho Kim,et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. , 2003, Carcinogenesis.
[31] E. Newcomb,et al. Cleavage of Bax enhances its cell death function. , 2000, Experimental cell research.
[32] M. Boyd,et al. Structure-activity requirements for flavone cytotoxicity and binding to tubulin. , 1998, Journal of medicinal chemistry.
[33] L. Pieters,et al. 4′‐Hydroxy‐3‐methoxyflavones with Potent Antipicornavirus Activity. , 1991 .
[34] L. Pieters,et al. 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. , 1991, Journal of medicinal chemistry.
[35] A. Strasser,et al. The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.
[36] R. Stierum,et al. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer–related mechanisms in colon cancer cells in vitro , 2005, European journal of nutrition.
[37] H. Kamata,et al. Redox regulation of cellular signalling. , 1999, Cellular signalling.
[38] Y. Vibhute,et al. STUDIES ON SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SOME NEW CHALCONES, FLAVONES AND FLAVONOLS , 1992 .